MiCardia's Series C Round

MiCardia raised a round of funding on July 10, 2012.

MiCardia is dedicated to designing, developing and commercializing methods for treating heart disease. The company is developing enCor, a dynamically activated annuloplasty device that corrects residu…

Articles about MiCardia's Series C Round: